Proceeding contribution from Paul Flynn (Labour) in the House of Commons on Thursday, 8 December 2005. It occurred during Estimates day on Department of Health.
Department of Health
I agree entirely; we could continue to record such successes at great length. Indeed, I think in my opening remarks I used the word ““miraculous”” when talking about the industry. I am trying to separate the job creation and the benefits to humankind, which have been enormous, as my hon. Friend said, from the marketing side of the industry. That is the whole point of the debate. We want to give the industry the pat on the back that it definitely needs, but we also want to draw attention to the points that the Health Committee legitimately raised.
Secondary information
- Type
- Proceeding contribution
- Reference
- 440 c1040
- Session
- 2005-06
- Chamber / Committee
- House of Commons chamber
- Subjects
- Advertising Licensing Expenditure Drugs Government departments Industry Prescription drugs Department of Health Medicines and Healthcare products Regulatory Agency Research Regulation Safety National Institute for Health and Care Excellence Registration Clinical trials
- Link
- View this Proceeding contribution on www.publications.parliament.uk
Librarians' tools
- Timestamp
- 2025-11-24 15:50:33 +0000
- URI
- http://data.parliament.uk/pimsdata/hansard/CONTRIBUTION_285124
- In Indexing
- http://indexing.parliament.uk/Content/Edit/1?uri=http://data.parliament.uk/pimsdata/hansard/CONTRIBUTION_285124
- In Solr
- https://search.parliament.uk/claw/solr/?id=http://data.parliament.uk/pimsdata/hansard/CONTRIBUTION_285124